The SMAD9 gene helps cells relay bone morphogenetic protein, or BMP, signals, which guide how bones form and how some blood vessels develop. If this gene does not work properly, those signals can become unbalanced. Depending on the variant, this may contribute to rare health problems such as pulmonary arterial hypertension, which is high pressure in the lung arteries, or unusually high bone mass. Changes in the SMAD9 gene are mainly relevant in rare disease genetics and specialist care.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or to regulate processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do the work. Other genes are mainly involved in controlling when certain processes happen, where they take place, and how strongly they run. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can find more information in the LearnHub.
Overview
SMAD9Gene function
What if the gene works
The SMAD9 gene helps cells pass along signals that shape bone and other tissues. This supports normal bone growth and helps guide how certain cells grow and mature.
Risk
What if the gene does not work
Changes in the SMAD9 gene can raise the chance of pulmonary arterial hypertension, where pressure in the lung arteries is abnormally high. Milder and more severe variants may influence whether symptoms appear and how early or pronounced they are.
Treatment
What does that mean for your treatment
For pathogenic variants in the SMAD9 gene, no SMAD9-specific treatment or drug-choice approach is currently established in clinical guidelines. The SMAD9 gene is being studied as a signaling target and biomarker in pulmonary vascular disease and bone growth, but this has not yet changed routine care.
Conditions associated with SMAD9
Gene function
What if the gene works
Your cells use the SMAD9 gene to pass along growth signals that help tissues develop and renew themselves. It is part of the BMP pathway, which helps cells know when to grow, mature, and make supportive structures such as bone. A key part of SMAD9 gene function in bone growth is helping cells turn outside messages into clear instructions inside the nucleus.
The SMAD9 gene helps cells receive BMP messages from their surface and carry those signals inward. This lets cells respond in an organized way to cues that guide normal development and tissue upkeep.
After a BMP signal arrives, the SMAD9 gene helps switch certain genes on or off in the nucleus. This gives cells a controlled way to follow growth and maturation instructions.
This gene contributes to the signaling that supports bone forming cells as they mature and do their work. By guiding these normal cell programs, it helps the body build and maintain the skeleton.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SMAD9 gene can change the protein’s shape, stability, or signaling activity, so cells pass along weaker growth signals. Some variants only partly reduce this signal, while more severe variants can leave little or no working protein. This range helps explain how SMAD9 gene variants affect protein function and, in SMAD9-related pulmonary arterial hypertension, may influence when features appear and how pronounced they are.
How variants are linked to conditions
Rare pathogenic variants in the SMAD9 gene are linked to heritable pulmonary arterial hypertension, and they are also found in some people diagnosed with idiopathic pulmonary arterial hypertension. In practice, the clearest SMAD9 gene and pulmonary arterial hypertension association is this rare inherited lung blood vessel condition, where a disease-causing variant can help confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a routine part of human biology. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. Still, in some situations, one well-characterized variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the SMAD9 gene. Risk appears to depend mainly on the specific SMAD9 change and family history, so people with concerns about their personal risk should speak with a doctor or genetic counselor.
Inheritance of SMAD9 variants
For SMAD9-related pulmonary arterial hypertension, the SMAD9 inheritance pattern is usually autosomal dominant. This means a person with a disease-causing variant in one copy of the SMAD9 gene can pass it to a child, with a 50% chance in each pregnancy. Because SMAD9 is on a non-sex chromosome, this inheritance pattern affects males and females similarly, and either parent can pass the variant to a son or daughter.
What does my SMAD9 result mean for my family?
For families with a disease-causing change in the SMAD9 gene, the pattern is usually dominant, which means close relatives such as parents, brothers, sisters, and children may also carry the same change. Some relatives may never develop symptoms, while others may be affected, so a family result can matter even when someone seems well. Because of that, first-degree relatives are often the family members most likely to want to discuss genetic testing.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the SMAD9 gene, a lab can analyze DNA from a blood sample, saliva, or cheek swab. This kind of genetic testing for SMAD9 variants reads the gene's sequence and compares it with the usual pattern to look for variants. Results may show a benign variant, a clinically relevant variant, or a finding that needs interpretation.
When should I consider getting a genetic test?
Consider genetic testing for the SMAD9 gene if you have pulmonary arterial hypertension, which is high blood pressure in the blood vessels of the lungs, especially if it started young or runs in your family. Testing may also be helpful if a close relative has a known SMAD9 variant.
A genetic result is only one part of your health story
Genetic findings can provide useful insight, although how much they reveal varies with the condition and the kind of variant present. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Part of that difference comes from how the body breaks down, transports, or responds to a drug. These differences are common and can influence both how well a medicine works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It focuses on gene drug relationships to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. Understanding this can support more informed and more individualized treatment decisions. More information on this topic is available in the LearnHub.
Drugs influenced by the SMAD9 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about treatment side effects, medication changes, or your general health are best discussed with your doctor or pharmacist.